Abstract:Open AccessMoreSectionsView PDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InRedditEmail Cite this article Wang Feng, Zhang Weihua, Wu Tianfeng and Chu Heying 2020Retraction: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progressionOpen Biol.10200204200204http://doi.org/10.1098/rsob.200204SectionOpen AccessRetractionRetraction: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression Feng Wang Feng Wang Google Scholar Find this author on PubMed Search for more papers by this author , Weihua Zhang Weihua Zhang Google Scholar Find this author on PubMed Search for more papers by this author , Tianfeng Wu Tianfeng Wu Google Scholar Find this author on PubMed Search for more papers by this author and Heying Chu Heying Chu Google Scholar Find this author on PubMed Search for more papers by this author Feng Wang Feng Wang Google Scholar Find this author on PubMed , Weihua Zhang Weihua Zhang Google Scholar Find this author on PubMed , Tianfeng Wu Tianfeng Wu Google Scholar Find this author on PubMed and Heying Chu Heying Chu Google Scholar Find this author on PubMed Published:22 July 2020https://doi.org/10.1098/rsob.200204This article retracts the followingResearch ArticleRETRACTED: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progressionhttps://doi.org/10.1098/rsob.180132 Feng Wang, Weihua Zhang, Tianfeng Wu and Heying Chu volume 8issue 10Open Biology31 October 2018 Open Biol. 8, 180132. (Published 31 October 2018). (doi:10.1098/rsob.180132) The Editor-in-Chief in agreement with the Publisher has retracted this article. Following an investigation, we have found that the published manuscript has substantial overlap with a previously published manuscript [1] in the text and figures (notably figure 1 Kaplan–Meier curves, table values, line graphs and figure 3 western blots). This paper has been identified among of a set of papers that present significant text and data duplication and therefore the data reported in this article are unreliable. The authors are in agreement with this retraction. Corresponding authors Yu Zhouxu ([email protected]) Feng Wang ([email protected]) Prof. Jon Pines FRS Editor-in-Chief, Open Biology Footnotes © 2020 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.ReferencesReference1. Yan X, Zhao J, Zhang R. 2017 Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression. Oncotarget 8, 49 064-49 075. (doi:10.18632/oncotarget.17093) Crossref, Google Scholar Previous Article VIEW FULL TEXT DOWNLOAD PDF FiguresRelatedReferencesDetailsRelated articlesRETRACTED: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression31 October 2018Open Biology This Issue July 2020Volume 10Issue 7 Article InformationDOI:https://doi.org/10.1098/rsob.200204PubMed:32692958Published by:Royal SocietyOnline ISSN:2046-2441History: Published online22/07/2020 License:© 2020 The Authors.Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited. Citations and impact Subjects biochemistry

Retraction: Reduced Interleukin-38 in Non-Small Cell Lung Cancer is Associated with Tumour Progression

Retraction: WSB2 as a target of Hedgehog signaling promoted the malignantbiological behavior of Xuanwei lung cancer through regulating Wnt/β-catenin signaling

Retraction: Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] Tissue‐specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA‐125a‐5p in lung cancer

[Retracted] Effect of RhoC on the epithelial‐mesenchymal transition process induced by TGF‐β1 in lung adenocarcinoma cells

[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling

miRNA-99b-5p Targets FZD8 to Inhibit Non-Small Cell Lung Cancer Proliferation, Migration and Invasion

[Retracted] MicroRNA‐320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1

[Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‐152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway

RETRACTED ARTICLE: Long Non-Coding RNA 91H Regulates IGF2 Expression by Interacting with IGF2BP2 and Promotes Tumorigenesis in Colorectal Cancer

RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781–790.

[Retracted] MicroRNA‐425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‐derived growth factor

[Retracted] LOC102724163 promotes breast cancer cell proliferation and invasion by stimulating MUC19 expression

RETRACTED: KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the β-catenin/STT3 signaling pathway

[Retracted] Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high‐throughput sequencing

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

Retraction: Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling

[Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‐mutated lung cancer cells